Form 8-K - Current report:
SEC Accession No. 0001193125-25-232558
Filing Date
2025-10-07
Accepted
2025-10-07 07:11:43
Documents
14
Period of Report
2025-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20251007.htm   iXBRL 8-K 62429
2 EX-1.1 acet-ex1_1.htm EX-1.1 581492
3 EX-4.1 acet-ex4_1.htm EX-4.1 105607
4 EX-5.1 acet-ex5_1.htm EX-5.1 21050
5 GRAPHIC img208765579_0.jpg GRAPHIC 32223
  Complete submission text file 0001193125-25-232558.txt   1041495

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20251007.xsd EX-101.SCH 25038
17 EXTRACTED XBRL INSTANCE DOCUMENT acet-20251007_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 251378247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)